TipRanks
Go Ultimate75% OFF

Kurt Hilzinger Insider Profile

11 Followers

Kurt Hilzinger, Director at Humana, holds 423.65K shares in Outlook Therapeutics (Ticker: OTLK), holds 18.52K shares in Oncobiologics Inc (Ticker: ONSIU), holds 19.45K shares in Humana (Ticker: HUM). Most recently, Kurt Hilzinger Bought ― shares of Outlook Therapeutics on May 27, 2026 for an estimated value of $176.00K.

Kurt Hilzinger's Trading History

OTLK
Outlook Therapeutics
May 27, 2026DirectorInformative Buy176.00K$184.71K
ONSIU
Oncobiologics Inc
Jan 24, 2017―Informative Buy120.36$87.40K
HUM
Humana
Jan 03, 2014DirectorUninformative Buy―$8.44M
COR
Cencora
―President & COO, Director―$58.84M

You May Also Like

Kurt Hilzinger insider profile FAQ

What is the percentage of profitable transactions made by Kurt Hilzinger?
The percentage of profitable transactions made by Kurt Hilzinger is 0%.
What is the average return per transaction made by Kurt Hilzinger?
The average return per transaction made by Kurt Hilzinger is -69.90%.
What stocks does Kurt Hilzinger hold?
Kurt Hilzinger holds: HUM, ONSIU, OTLK, COR stocks.
What was Kurt Hilzinger’s latest transaction?
Kurt Hilzinger’s latest transaction was an Informative Buy of $176.00K.
What was Kurt Hilzinger's most profitable transaction?
Kurt Hilzinger’s most profitable transaction was an Informative Buy of OTLK stock on February 23, 2022. The return on the trade was -17.30%.
What is Kurt Hilzinger's role in Humana?
Kurt Hilzinger's role in Humana is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.